NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • XYZ.
  • XY.
  • #TrumpTrade
  • Invest ↗
Sign in Subscribe

Coca-Cola Beats Expectations with 6% Growth Despite Higher Prices

Coca-Cola's Q3 results exceed Wall Street forecasts with 6% organic revenue growth, driven by zero-sugar drinks, smaller packages, and strategic pricing across global markets.

Coca-Cola Beats Expectations with 6% Growth Despite Higher Prices
Photo by happy ant on Unsplash
Already have an account? Sign in.
Featured/ 10/21/2025 · 8:07 AM
KO
/ Read more

Feed↓

Axon Shares Plunge After Missing Q3 Profit Estimates Amid Tariff Pressures
11/05/2025 · 12:43 PM

Axon Shares Plunge After Missing Q3 Profit Estimates Amid Tariff Pressures

Axon Enterprise shares drop 10% after missing profit estimates due to rising tariff costs. The Taser-maker raises 2025 revenue outlook and announces a $625M Carbyne acquisition.

/ Subscriber only
Perrigo Rethinks Its Baby Formula Business
11/05/2025 · 11:59 AM

Perrigo Rethinks Its Baby Formula Business

Perrigo reviews its store-brand baby formula business due to quality issues. It is shifting focus to higher-profit health brands instead.

/ Subscriber only
FDA Greenlights Linaclotide (Linzess) for Children 7 Years and Older with Irritable Bowel Syndrome with Constipation
11/05/2025 · 11:40 AM

FDA Greenlights Linaclotide (Linzess) for Children 7 Years and Older with Irritable Bowel Syndrome with Constipation

Ironwood's Linzess is the first FDA-approved drug for children 7+ with IBS-C (chronic constipation, pain, and bloating).

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe